StreetAlpha.app
Home › Stocks › BAX

Baxter International Inc (BAX)

Healthcare
$25.77
▲ +0.88%
LAST CLOSE · NOV 17

Baxter makes IV solutions, infusion systems, pharmaceuticals and other medical products for hospitals and patients at home. It last closed at $25.77 on Nov 17, up 0.88% on the day. BAX reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 4 analysts is $25.00 (-3.0% from the last close), with a high of $27.00 and a low of $23.00. Analyst consensus is Hold, based on the latest ratings from 4 firms (0 buy, 3 hold, 1 sell). In the past 30 days there were 1 dark pool print totaling $6.3M, the largest $6.3M.

AI Auto Pilots
Is BAX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$11.6B
+5.3% vs a year ago
Net income
−$723.0M
−6.2% margin
EPS (diluted)
−$1.42
Gross margin
30.1%
$3.5B gross profit
Valuation
Market cap
$13.3B
517.3M shares
P/E
–
No P/E while losing money
Price to sales
1.1
Market cap over revenue
Dividend yield
0.16%
$0.04 a share over 12 months
Balance sheet
Cash & equivalents
$2.0B
At Sep 30
Shareholder equity
$6.5B
Shares outstanding
517.3M
At Oct 22
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $12.1B$12.1BFY2021FY2022: $10.1B$10.1BFY2022FY2023: $10.4B$10.4BFY2023FY2024: $10.6B$10.6BFY2024FY2025: $11.2B$11.2BFY2025

From BAX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
$0.60
$3.09B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
4firms
0 Buy3 Hold1 Sell
Each firm's latest rating on BAX in the past 90 days
Average 12-month target
$25.00
▼ 3.0% downside

Based on 4 analysts who set a price target on BAX in the past 90 days. The average target is $25.00, with a high of $27.00 and a low of $23.00, compared with the last close of $25.77.

Low $23.00Avg $25.00High $27.00
Blue marker: last close $25.77
Highest target$27.00
Average target$25.00
Lowest target$23.00
Latest rating changes
BarclaysMaintained
Nov 9Sell$23
JP MorganMaintained
Oct 30Hold$25
Wells FargoTarget raised
Oct 30Hold$23 → $25
BarclaysInitiated
Oct 7Sell$20
CitigroupTarget lowered
Oct 5Hold$28 → $27
DateFirmActionRatingPrice target
Nov 9BarclaysMaintainedSell$23
Oct 30JP MorganMaintainedHold$25
Oct 30Wells FargoTarget raisedHold$23 → $25
Oct 7BarclaysInitiatedSell$20
Oct 5CitigroupTarget loweredHold$28 → $27
Loading…

Technical Analysis

BAX · as of the Nov 17 close · updated after every close
Uptrend

The stock is 2% above its 20 day and 5% above its 50 day average. It is 16% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 54). The nearest support is the swing low (Aug 18) at $25.75, and the nearest resistance the swing high (Oct 16) at $25.99.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 3.7%/day
Key levels
$30.0052 week high+16.4%
$26.10Pivot R1+1.3%
$25.99Swing high (Oct 16)+0.9%
$25.77Last close
$25.75Swing low (Aug 18)−0.1%
$25.61Pivot−0.6%
$25.3720 day average−1.6%
$25.28Pivot S1−1.9%
$24.66100 day average−4.3%
$24.5550 day average−4.7%
$21.70200 day average−15.8%
$15.7352 week low−39.0%
Indicators
RSI (14)53.85Middle of its rangeNeutral
MACD0.35Above its signal lineBullish
Stochastic69.9Middle of its rangeNeutral
ADX (14)15.9No clear trend
Williams %R-28.8Oversold below −80, overbought above −20Neutral
CCI (20)26.9Oversold below −100, overbought above 100Neutral
Rate of change+1.1%Change over 10 sessionsBullish
ATR (14)$0.94Typical daily range, 3.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for BAX

What happened before

See how BAX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BAX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BAX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BAX in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$6.3M
Largest print
$6.3M
Loading…

BAX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲374 buying vs 264 selling
  • ▼Held by funds -7.2 pts
  • ▲Funds holding +43
  • ▲Superinvestors: 3 added, 0 cut
  • ▲Put/call 0.57 to 0.52
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding736693+6.2%
In funds' top 1010100.0%
Held by funds100.6%107.8%−7.2 pts
New / increased122 / 25296 / 253+7.2%
Reduced / sold out198 / 66195 / 75−2.2%
Put/call ratio0.520.57−9.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BAX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BAX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$1.3B
9.8% of value
Shares outstanding, 12 months
+0.6%
More shares
Last quarter
—
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BAX is in one of them and how their past BAX trades turned out.

BAX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BAX in an article yet. Here's the latest on the wider market.

BAX Congress Trades

All congress trades →
Trades, 12 months
18
Buys
12
67%
Sells
6
33%
People
4
Last filed Sep 22
Who traded BAX · since 2015
Latest 5 filings of 163
$15K – $50KTraded Jul 23, 2026Filed Sep 22, 2026
$1K – $15KTraded May 18, 2026Filed Jul 1, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
$1K – $15KTraded May 27, 2026Filed Jun 9, 2026
$1K – $15KTraded May 15, 2026Filed Jun 9, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KJul 23, 2026Sep 22, 202661 d
Donald J TrumpExecutive branchBuy$1K – $15KMay 18, 2026Jul 1, 202644 d
Donald J TrumpExecutive branchSell$1K – $15KMay 15, 2026Jul 1, 202647 d
Ro KhannaD · CABuy$1K – $15KMay 27, 2026Jun 9, 202613 d
Ro KhannaD · CABuy$1K – $15KMay 15, 2026Jun 9, 202625 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Baxter International

Baxter is a healthcare products company based in Deerfield, Illinois. It makes sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, injectable pharmaceuticals, surgical hemostat and sealant products, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Its customers include hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home. Its products are sold in many countries around the world.

Headquarters
Deerfield, IL
Founded
1931